233 related articles for article (PubMed ID: 23411782)
1. The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.
Ooi JD; Chang J; O'Sullivan KM; Pedchenko V; Hudson BG; Vandenbark AA; Fugger L; Holdsworth SR; Kitching AR
J Am Soc Nephrol; 2013 Feb; 24(3):419-31. PubMed ID: 23411782
[TBL] [Abstract][Full Text] [Related]
2. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.
Bolton WK; Chen L; Hellmark T; Wieslander J; Fox JW
J Am Soc Nephrol; 2005 Sep; 16(9):2657-66. PubMed ID: 16049074
[TBL] [Abstract][Full Text] [Related]
3. Molecular mapping of the Goodpasture's epitope for glomerulonephritis.
Bolton WK; Chen L; Hellmark T; Fox J; Wieslander J
Trans Am Clin Climatol Assoc; 2005; 116():229-36; discussion 237-8. PubMed ID: 16555617
[TBL] [Abstract][Full Text] [Related]
4. The critical amino acids of a nephritogenic epitope on human Goodpasture autoantigen for binding to HLA-DRB1*1501.
Gu QH; Jia XY; Li JN; Chen FJ; Cui Z; Zhao MH
Mol Immunol; 2017 Aug; 88():1-9. PubMed ID: 28570922
[TBL] [Abstract][Full Text] [Related]
5. The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.
Xie LJ; Cui Z; Chen FJ; Pei ZY; Hu SY; Gu QH; Jia XY; Zhu L; Zhou XJ; Zhang H; Liao YH; Lai LH; Hudson BG; Zhao MH
Immunology; 2017 Aug; 151(4):395-404. PubMed ID: 28342268
[TBL] [Abstract][Full Text] [Related]
6. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
Phelps RG; Jones V; Turner AN; Rees AJ
Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis.
Robertson J; Wu J; Arends J; Glass W; Southwood S; Sette A; Lou YH
Kidney Int; 2005 Sep; 68(3):1061-70. PubMed ID: 16105036
[TBL] [Abstract][Full Text] [Related]
8. Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.
Reynolds J; Haxby J; Juggapah JK; Evans DJ; Pusey CD
Clin Exp Immunol; 2009 Feb; 155(2):311-9. PubMed ID: 19040602
[TBL] [Abstract][Full Text] [Related]
9. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
Ooi JD; Holdsworth SR; Kitching AR
J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
[TBL] [Abstract][Full Text] [Related]
10. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
[TBL] [Abstract][Full Text] [Related]
11. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.
Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH
J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
Luo AM; Fox JW; Chen L; Bolton WK
J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
[TBL] [Abstract][Full Text] [Related]
13. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease.
Cairns LS; Phelps RG; Bowie L; Hall AM; Saweirs WW; Rees AJ; Barker RN
J Am Soc Nephrol; 2003 Nov; 14(11):2801-12. PubMed ID: 14569090
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers.
Olaru F; Wang XP; Luo W; Ge L; Miner JH; Kleinau S; Geiger XJ; Wasiluk A; Heidet L; Kitching AR; Borza DB
J Immunol; 2013 Feb; 190(4):1424-32. PubMed ID: 23303673
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR15-specific inhibition attenuates autoreactivity to the Goodpasture antigen.
Huynh M; Eggenhuizen PJ; Olson GL; Rao NB; Self CR; Sun Y; Holdsworth SR; Kitching AR; Ooi JD
J Autoimmun; 2019 Sep; 103():102276. PubMed ID: 31104947
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
17. Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen.
Zhang Y; Su SC; Hecox DB; Brady GF; Mackin KM; Clark AG; Foster MH
J Immunol; 2008 Nov; 181(9):6092-100. PubMed ID: 18941198
[TBL] [Abstract][Full Text] [Related]
18. Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1.
Meyers KE; Christensen M; Madaio MP
Am J Nephrol; 2009; 30(5):474-80. PubMed ID: 19786737
[TBL] [Abstract][Full Text] [Related]
19. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
MacDonald BA; Sund M; Grant MA; Pfaff KL; Holthaus K; Zon LI; Kalluri R
Blood; 2006 Mar; 107(5):1908-15. PubMed ID: 16254142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]